Hong Kong (China)
Asia’s LP landscape: North to south
Pools of institutional – and less institutional – capital in Asia are deepening, but it remains a multi-speed market with some investors just beginning their alternatives journey and others achieving maturity
Deal focus: isBIM targets real estate’s digitisation catch-up
A renewed focus on safety and sustainability has prompted property developers to consider technology-enabled fixes. IsBIM is riding the wave from Greater China through Asia and the Middle East
Hong Kong blockchain fund raises $100m
Hong Kong blockchain specialist CMCC Global has reached a first close on its latest financial technology and web3 fund, raising the full targeted amount of USD 100m.
MTR Lab, Gobi back Hong Kong construction tech start-up
MTR Lab, a technology and innovation arm of Hong Kong transport operator MTR, has teamed up with Gobi Partners to invest HKD 46.8m (USD 5.9m) in local sustainable construction start-up isBIM.
China GP Tiantu Capital targets $253m Hong Kong IPO
Chinese consumer-focused venture capital firm Tiantu Capital has launched a Hong Kong IPO with a view to raising as much as HKD 1.9bn (USD 253m).
Family offices: A role for Hong Kong?
Hong Kong’s package of incentives for family offices is intended to redress a balance that has swung in favour of Singapore. Geopolitics is dampening its competitive advantages
Hony looks to raise SPAC in Hong Kong
Chinese private equity firm Hony Capital has filed to raise a special purpose acquisition company (SPAC) in Hong Kong, having previously failed to get traction with a similar structure in the US.
Hong Kong virtual insurer Bowtie gets $35m Series B
Hong Kong digital life insurance company Bowtie has closed a USD 34.9m Series B round led by the local unit of Sun Life Financial.
Hong Kong's C Capital secures $250m for latest PE fund
C Capital, an investment firm established by Adrian Cheng, scion of Hong Kong’s New World Development, has closed its latest private equity fund with around USD 250m in commitments.
PE-backed Zhaogang to list via Hong Kong SPAC merger
Zhaogang, a private equity-backed Chinese B2B steel-trading platform, is on course to become the first company to list in Hong Kong through a merger with a special purpose acquisition company (SPAC).
Deal focus: Longreach hits homerun with Quasar
The Longreach Group transitioned Quasar Medical to professional management, took it into new markets, and diversified the company’s manufacturing footprint. A 7x return was its reward
Vietnam's VinFast completes SPAC merger, sees volatile trading debut
Vietnam-based electric vehicle (EV) manufacturer VinFast saw its stock climb 287% and then fall back by 47% during the first two days of trading following one of the largest mergers to date with a US-listed special purpose acquisition company (SPAC).
AGIC backs Singapore medical device manufacturer
Hong Kong-headquartered AGIC Capital, an Asia-Europe cross-border specialist, has led a growth equity round of undisclosed size for Singapore-based medical devices maker AP Technologies.
Gobi reaches $256m target for Greater Bay Area fund
Gobi Partners has reached its HKD 2bn (USD 256m) target for AEF Greater Bay Area (GBA) Fund, the successor to Alibaba Hong Kong Entrepreneurs Fund, according to Chibo Tang, a managing partner with the firm.
Hong Kong's Micro Connect raises $458m Series C
Hong Kong’s Micro Connect, a financier for micro, small, and medium-sized enterprises (MSMEs), has raised USD 458m in Series C funding. It did not name the investors.
PE-backed Adlai Nortye pursues US listing
Adlai Nortye, a private equity-backed Chinese cancer drug developer that previously filed to list in Hong Kong, is now targeting an IPO in the US.
Longreach sells Hong Kong medical devices player to Boyu
The Longreach Group has sold Quasar Medical, a Hong Kong-headquartered medical devices manufacturer it has owned since 2019, to Boyu Capital for an undisclosed sum.
BPEA EQT completes Vistra, Tricor merger
BPEA EQT has completed the merger of Asia-headquartered corporate services providers Vistra Group and Tricor Group through a transaction that values the combined business at USD 6.5bn.
Hong Kong's Immuno Cure raises $27m
Hong Kong’s Immuno Cure BioTech, a vaccine and antibodies developer focused on cancers, inflammatory and infectious diseases, has raised USD 27m in Series A funding featuring Gobi Partners.
Hong Kong's VMS pursues institutional upgrade
VMS Group will reach out to fund-of-funds with China or regional mandates for its new flagship private equity fund, which is intended to mark the firm's transition from a platform that primarily serves Hong Kong family offices to one that is more institutional...
Black Sesame leads surge in Hong Kong IPO filings
Black Sesame International Holding, a Chinese chipmaker specialising in autonomous driving applications, is among the highest-profile companies in the latest batch targeting IPOs on the Hong Kong Stock Exchange.
EmergeVest faces legal action from LP
EmergeVest is facing legal action from one of its LPs – also a key early partner in the formation of the firm’s global logistics platform, EV Cargo – who wants to receive his share of the principal and profits.
Hong Kong's OneDegree upsizes Series B to $55m
Hong Kong insurance start-up OneDegree has raised USD 27m from a group including Gobi Partners. It is billed as an extension to a Series B round from 2021, bringing the overall total to USD 55m.